Position in NTRA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$613,748
+$399,559 QoQ
Shares Held
2,261
+111.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#500
of 844 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 84%
Shared 4%
None 12%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Savant Capital, LLC holds $66,612,472 across 15 Diagnostics & Research names. NTRA ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
47,809 | $23,969,520 | |
| 2 | DGX |
Quest Diagnostics Inc
|
61,498 | $13,034,501 | |
| 3 | DHR |
Danaher Corp /De/
|
58,272 | $11,099,650 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
28,502 | $5,507,156 | |
| 5 | WAT |
Waters Corp /De/
|
10,991 | $4,122,064 | |
| 6 | LH |
Labcorp Holdings Inc.
|
10,985 | $3,075,800 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
1,097 | $1,401,428 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
1,969 | $1,036,560 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $613,748 | 2,261 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $214,189 | 1,071 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $237,337 | 1,036 | Shares | Sole | 2026-02-10 | |
| 2024-12-31 | $2,997,093 | 18,933 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $2,370,664 | 18,674 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,977,375 | 18,260 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $588,362 | 6,433 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||